M

Active Director Director DIN 09515841
DIN 09515841 First appointment Feb 2022 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Murugan

Data last updated:

Murugan is a Director at Medigrow Biotech Private Limited (since 2022). The company operates in Business Services. Medigrow Biotech Private Limited reported revenue of ₹9.54 Cr (FY 2019).

DIN 09515841
Primary Designation Director
Industry Business Services
First Appointment 26 Feb 2022
Oldest Company Age 9 yrs
Largest company Medigrow Biotech Private Limited · ₹9.54 Cr (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medigrow Biotech Private Limited U74999TN2017PTC114155
Director26 Feb 20222017₹9.54 Cr (FY 2019)Active

Board colleagues of Murugan

NameDINCompanyDesignation
Balakrishnan Prabhu07339646Medigrow Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medigrow Biotech Private Limited
Premium access

Shareholding and investment profile for Murugan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Murugan

Murugan currently holds 1 directorship: Medigrow Biotech Private Limited (Director, since 26 Feb 2022, revenue ₹9.54 Cr (FY 2019)).

Murugan was first appointed on 26 Feb 2022 as Director at Medigrow Biotech Private Limited.

The current boards of Murugan's companies include Balakrishnan Prabhu (Medigrow Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available